Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lubetzki, C
Right arrow Articles by Zalc, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lubetzki, C
Right arrow Articles by Zalc, B

NEUROLOGY 1986;36:524-528
© 1986 American Academy of Neurology

ARTICLES

Multiple sclerosis: rat and human oligodendrocytes are not the target for CSF immunoglobulins

C Lubetzki, P Lombrail, JJ Hauw and B Zalc

CSF Ig from 28 patients with MS and 25 patients with other neurologic diseases (OND) were examined for their capacity to bind to rat or human oligodendrocytes in culture. We have used a double-label approach combining CSF Ig with antibodies against galactocerebroside (GalC). As normal human IgG at a concentration higher than 250 micrograms/ml were found to bind nonspecifically to oligodendrocytes in culture, patients' CSFs were used unconcentrated, at a final IgG concentration never exceeding 115 micrograms/ml. In these experimental conditions, we have not been able to detect any fixation of CSF Ig from MS (or OND) patients to rat or human GalC+ oligodendrocytes.


This article has been cited by other articles:


Home page
 Mult SclerHome page
M Podbielska and E. Hogan
Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Multiple Sclerosis, September 1, 2009; 15(9): 1011 - 1029.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
C. Jaillard, S. Harrison, B. Stankoff, M. S. Aigrot, A. R. Calver, G. Duddy, F. S. Walsh, M. N. Pangalos, N. Arimura, K. Kaibuchi, et al.
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
J. Neurosci., February 9, 2005; 25(6): 1459 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
O. Lily, J. Palace, and A. Vincent
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
Brain, February 1, 2004; 127(2): 269 - 279.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.